nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—UGT2B15—gall bladder—pancreatic cancer	0.0423	0.293	CbGeAlD
Lorazepam—UGT2B15—islet of Langerhans—pancreatic cancer	0.0277	0.192	CbGeAlD
Lorazepam—UGT2B15—pancreas—pancreatic cancer	0.0195	0.135	CbGeAlD
Lorazepam—UGT2B15—digestive system—pancreatic cancer	0.0166	0.115	CbGeAlD
Lorazepam—TSPO—islet of Langerhans—pancreatic cancer	0.00992	0.0688	CbGeAlD
Lorazepam—GABRB3—islet of Langerhans—pancreatic cancer	0.00901	0.0624	CbGeAlD
Lorazepam—TSPO—pancreas—pancreatic cancer	0.00697	0.0483	CbGeAlD
Lorazepam—GABRB3—pancreas—pancreatic cancer	0.00633	0.0439	CbGeAlD
Lorazepam—TSPO—digestive system—pancreatic cancer	0.00596	0.0413	CbGeAlD
Lorazepam—Thinking abnormal—Doxorubicin—pancreatic cancer	0.00211	0.00246	CcSEcCtD
Lorazepam—Hepatocellular injury—Epirubicin—pancreatic cancer	0.00209	0.00244	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Epirubicin—pancreatic cancer	0.00209	0.00244	CcSEcCtD
Lorazepam—Injection site reaction—Epirubicin—pancreatic cancer	0.00207	0.00242	CcSEcCtD
Lorazepam—Liver function test abnormal—Docetaxel—pancreatic cancer	0.00207	0.00242	CcSEcCtD
Lorazepam—Convulsion—Sunitinib—pancreatic cancer	0.00206	0.0024	CcSEcCtD
Lorazepam—Hypertension—Sunitinib—pancreatic cancer	0.00205	0.0024	CcSEcCtD
Lorazepam—Dysarthria—Doxorubicin—pancreatic cancer	0.00204	0.00238	CcSEcCtD
Lorazepam—Cystitis noninfective—Epirubicin—pancreatic cancer	0.00204	0.00238	CcSEcCtD
Lorazepam—Salivary hypersecretion—Epirubicin—pancreatic cancer	0.00203	0.00237	CcSEcCtD
Lorazepam—Chills—Irinotecan—pancreatic cancer	0.00202	0.00236	CcSEcCtD
Lorazepam—Cystitis—Epirubicin—pancreatic cancer	0.00201	0.00235	CcSEcCtD
Lorazepam—Arrhythmia—Irinotecan—pancreatic cancer	0.00201	0.00235	CcSEcCtD
Lorazepam—Atrioventricular block—Doxorubicin—pancreatic cancer	0.00199	0.00233	CcSEcCtD
Lorazepam—Alopecia—Irinotecan—pancreatic cancer	0.00199	0.00232	CcSEcCtD
Lorazepam—Dry mouth—Sunitinib—pancreatic cancer	0.00198	0.00231	CcSEcCtD
Lorazepam—Chills—Gemcitabine—pancreatic cancer	0.00196	0.00229	CcSEcCtD
Lorazepam—Arrhythmia—Gemcitabine—pancreatic cancer	0.00196	0.00228	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00195	0.00228	CcSEcCtD
Lorazepam—Fatigue—Tamoxifen—pancreatic cancer	0.00195	0.00228	CcSEcCtD
Lorazepam—Pain—Tamoxifen—pancreatic cancer	0.00193	0.00226	CcSEcCtD
Lorazepam—Constipation—Tamoxifen—pancreatic cancer	0.00193	0.00226	CcSEcCtD
Lorazepam—Alopecia—Gemcitabine—pancreatic cancer	0.00193	0.00226	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00193	0.00226	CcSEcCtD
Lorazepam—Hepatocellular injury—Doxorubicin—pancreatic cancer	0.00193	0.00226	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Doxorubicin—pancreatic cancer	0.00193	0.00226	CcSEcCtD
Lorazepam—Fatigue—Erlotinib—pancreatic cancer	0.00193	0.00226	CcSEcCtD
Lorazepam—Infection—Sunitinib—pancreatic cancer	0.00193	0.00225	CcSEcCtD
Lorazepam—Arrhythmia—Fluorouracil—pancreatic cancer	0.00192	0.00225	CcSEcCtD
Lorazepam—Injection site reaction—Doxorubicin—pancreatic cancer	0.00192	0.00224	CcSEcCtD
Lorazepam—Constipation—Erlotinib—pancreatic cancer	0.00191	0.00224	CcSEcCtD
Lorazepam—Pain—Erlotinib—pancreatic cancer	0.00191	0.00224	CcSEcCtD
Lorazepam—Coma—Epirubicin—pancreatic cancer	0.00191	0.00223	CcSEcCtD
Lorazepam—Erythema—Gemcitabine—pancreatic cancer	0.00191	0.00223	CcSEcCtD
Lorazepam—Alopecia—Fluorouracil—pancreatic cancer	0.0019	0.00222	CcSEcCtD
Lorazepam—Thrombocytopenia—Sunitinib—pancreatic cancer	0.0019	0.00222	CcSEcCtD
Lorazepam—Bladder pain—Epirubicin—pancreatic cancer	0.00189	0.0022	CcSEcCtD
Lorazepam—Cystitis noninfective—Doxorubicin—pancreatic cancer	0.00189	0.0022	CcSEcCtD
Lorazepam—Salivary hypersecretion—Doxorubicin—pancreatic cancer	0.00187	0.00219	CcSEcCtD
Lorazepam—Erythema—Fluorouracil—pancreatic cancer	0.00187	0.00219	CcSEcCtD
Lorazepam—Cystitis—Doxorubicin—pancreatic cancer	0.00186	0.00218	CcSEcCtD
Lorazepam—Pulmonary oedema—Epirubicin—pancreatic cancer	0.00186	0.00217	CcSEcCtD
Lorazepam—Pancytopenia—Docetaxel—pancreatic cancer	0.00184	0.00215	CcSEcCtD
Lorazepam—Mental disability—Epirubicin—pancreatic cancer	0.00181	0.00212	CcSEcCtD
Lorazepam—Vision blurred—Fluorouracil—pancreatic cancer	0.00177	0.00206	CcSEcCtD
Lorazepam—Coma—Doxorubicin—pancreatic cancer	0.00176	0.00206	CcSEcCtD
Lorazepam—Vertigo—Irinotecan—pancreatic cancer	0.00176	0.00205	CcSEcCtD
Lorazepam—Bladder pain—Doxorubicin—pancreatic cancer	0.00175	0.00204	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Epirubicin—pancreatic cancer	0.00174	0.00203	CcSEcCtD
Lorazepam—Pulmonary oedema—Doxorubicin—pancreatic cancer	0.00172	0.00201	CcSEcCtD
Lorazepam—Hypertension—Irinotecan—pancreatic cancer	0.00169	0.00197	CcSEcCtD
Lorazepam—Jaundice—Docetaxel—pancreatic cancer	0.00169	0.00197	CcSEcCtD
Lorazepam—Mental disability—Doxorubicin—pancreatic cancer	0.00168	0.00196	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00167	0.00196	CcSEcCtD
Lorazepam—Fatigue—Sunitinib—pancreatic cancer	0.00167	0.00195	CcSEcCtD
Lorazepam—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00167	0.00195	CcSEcCtD
Lorazepam—Pain—Sunitinib—pancreatic cancer	0.00166	0.00194	CcSEcCtD
Lorazepam—Constipation—Sunitinib—pancreatic cancer	0.00166	0.00194	CcSEcCtD
Lorazepam—Hypertension—Gemcitabine—pancreatic cancer	0.00165	0.00192	CcSEcCtD
Lorazepam—Asthenia—Tamoxifen—pancreatic cancer	0.00162	0.0019	CcSEcCtD
Lorazepam—Convulsion—Fluorouracil—pancreatic cancer	0.00162	0.0019	CcSEcCtD
Lorazepam—Agranulocytosis—Docetaxel—pancreatic cancer	0.00161	0.00189	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Doxorubicin—pancreatic cancer	0.00161	0.00188	CcSEcCtD
Lorazepam—Confusional state—Irinotecan—pancreatic cancer	0.00161	0.00188	CcSEcCtD
Lorazepam—Asthenia—Erlotinib—pancreatic cancer	0.00161	0.00188	CcSEcCtD
Lorazepam—Infection—Irinotecan—pancreatic cancer	0.00159	0.00185	CcSEcCtD
Lorazepam—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00156	0.00183	CcSEcCtD
Lorazepam—Lethargy—Epirubicin—pancreatic cancer	0.00155	0.00181	CcSEcCtD
Lorazepam—Infection—Gemcitabine—pancreatic cancer	0.00154	0.00181	CcSEcCtD
Lorazepam—Confusional state—Fluorouracil—pancreatic cancer	0.00154	0.0018	CcSEcCtD
Lorazepam—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00152	0.00178	CcSEcCtD
Lorazepam—Hyponatraemia—Epirubicin—pancreatic cancer	0.00152	0.00178	CcSEcCtD
Lorazepam—Infection—Fluorouracil—pancreatic cancer	0.00152	0.00177	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.00151	0.00177	CcSEcCtD
Lorazepam—Osteoarthritis—Epirubicin—pancreatic cancer	0.00151	0.00177	CcSEcCtD
Lorazepam—Diplopia—Epirubicin—pancreatic cancer	0.00151	0.00177	CcSEcCtD
Lorazepam—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.0015	0.00175	CcSEcCtD
Lorazepam—Visual impairment—Docetaxel—pancreatic cancer	0.0015	0.00175	CcSEcCtD
Lorazepam—Dizziness—Tamoxifen—pancreatic cancer	0.0015	0.00175	CcSEcCtD
Lorazepam—Tachycardia—Fluorouracil—pancreatic cancer	0.00149	0.00174	CcSEcCtD
Lorazepam—Hypotension—Irinotecan—pancreatic cancer	0.00149	0.00174	CcSEcCtD
Lorazepam—Dizziness—Erlotinib—pancreatic cancer	0.00148	0.00173	CcSEcCtD
Lorazepam—Hypotension—Gemcitabine—pancreatic cancer	0.00145	0.0017	CcSEcCtD
Lorazepam—Cardiac arrest—Epirubicin—pancreatic cancer	0.00144	0.00168	CcSEcCtD
Lorazepam—Vomiting—Tamoxifen—pancreatic cancer	0.00144	0.00168	CcSEcCtD
Lorazepam—Lethargy—Doxorubicin—pancreatic cancer	0.00143	0.00167	CcSEcCtD
Lorazepam—Hypotension—Fluorouracil—pancreatic cancer	0.00143	0.00167	CcSEcCtD
Lorazepam—Hypersensitivity—Sunitinib—pancreatic cancer	0.00143	0.00167	CcSEcCtD
Lorazepam—Rash—Tamoxifen—pancreatic cancer	0.00143	0.00167	CcSEcCtD
Lorazepam—Dermatitis—Tamoxifen—pancreatic cancer	0.00143	0.00167	CcSEcCtD
Lorazepam—Ataxia—Epirubicin—pancreatic cancer	0.00142	0.00166	CcSEcCtD
Lorazepam—Vomiting—Erlotinib—pancreatic cancer	0.00142	0.00166	CcSEcCtD
Lorazepam—Somnolence—Irinotecan—pancreatic cancer	0.00142	0.00166	CcSEcCtD
Lorazepam—Headache—Tamoxifen—pancreatic cancer	0.00142	0.00166	CcSEcCtD
Lorazepam—Rash—Erlotinib—pancreatic cancer	0.00141	0.00165	CcSEcCtD
Lorazepam—Dermatitis—Erlotinib—pancreatic cancer	0.00141	0.00165	CcSEcCtD
Lorazepam—Hyponatraemia—Doxorubicin—pancreatic cancer	0.00141	0.00164	CcSEcCtD
Lorazepam—Headache—Erlotinib—pancreatic cancer	0.0014	0.00164	CcSEcCtD
Lorazepam—Osteoarthritis—Doxorubicin—pancreatic cancer	0.0014	0.00164	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.0014	0.00164	CcSEcCtD
Lorazepam—Diplopia—Doxorubicin—pancreatic cancer	0.0014	0.00164	CcSEcCtD
Lorazepam—Liver function test abnormal—Epirubicin—pancreatic cancer	0.0014	0.00163	CcSEcCtD
Lorazepam—Chills—Docetaxel—pancreatic cancer	0.00139	0.00163	CcSEcCtD
Lorazepam—Asthenia—Sunitinib—pancreatic cancer	0.00139	0.00162	CcSEcCtD
Lorazepam—Arrhythmia—Docetaxel—pancreatic cancer	0.00139	0.00162	CcSEcCtD
Lorazepam—Somnolence—Gemcitabine—pancreatic cancer	0.00138	0.00162	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00138	0.00161	CcSEcCtD
Lorazepam—Fatigue—Irinotecan—pancreatic cancer	0.00138	0.00161	CcSEcCtD
Lorazepam—Alopecia—Docetaxel—pancreatic cancer	0.00137	0.0016	CcSEcCtD
Lorazepam—Pain—Irinotecan—pancreatic cancer	0.00137	0.0016	CcSEcCtD
Lorazepam—Constipation—Irinotecan—pancreatic cancer	0.00137	0.0016	CcSEcCtD
Lorazepam—Somnolence—Fluorouracil—pancreatic cancer	0.00136	0.00159	CcSEcCtD
Lorazepam—Erythema—Docetaxel—pancreatic cancer	0.00135	0.00158	CcSEcCtD
Lorazepam—Nausea—Tamoxifen—pancreatic cancer	0.00134	0.00157	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00134	0.00157	CcSEcCtD
Lorazepam—Fatigue—Gemcitabine—pancreatic cancer	0.00134	0.00157	CcSEcCtD
Lorazepam—Cardiac arrest—Doxorubicin—pancreatic cancer	0.00133	0.00156	CcSEcCtD
Lorazepam—Pain—Gemcitabine—pancreatic cancer	0.00133	0.00155	CcSEcCtD
Lorazepam—Constipation—Gemcitabine—pancreatic cancer	0.00133	0.00155	CcSEcCtD
Lorazepam—Nausea—Erlotinib—pancreatic cancer	0.00133	0.00155	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00132	0.00154	CcSEcCtD
Lorazepam—Ataxia—Doxorubicin—pancreatic cancer	0.00132	0.00154	CcSEcCtD
Lorazepam—Feeling abnormal—Irinotecan—pancreatic cancer	0.00132	0.00154	CcSEcCtD
Lorazepam—Pain—Fluorouracil—pancreatic cancer	0.00131	0.00153	CcSEcCtD
Lorazepam—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.00129	0.00151	CcSEcCtD
Lorazepam—Dizziness—Sunitinib—pancreatic cancer	0.00128	0.0015	CcSEcCtD
Lorazepam—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00128	0.0015	CcSEcCtD
Lorazepam—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00126	0.00147	CcSEcCtD
Lorazepam—Pancytopenia—Epirubicin—pancreatic cancer	0.00124	0.00145	CcSEcCtD
Lorazepam—Vomiting—Sunitinib—pancreatic cancer	0.00123	0.00144	CcSEcCtD
Lorazepam—Rash—Sunitinib—pancreatic cancer	0.00122	0.00143	CcSEcCtD
Lorazepam—Dermatitis—Sunitinib—pancreatic cancer	0.00122	0.00143	CcSEcCtD
Lorazepam—Headache—Sunitinib—pancreatic cancer	0.00121	0.00142	CcSEcCtD
Lorazepam—Hypersensitivity—Irinotecan—pancreatic cancer	0.00118	0.00137	CcSEcCtD
Lorazepam—Convulsion—Docetaxel—pancreatic cancer	0.00117	0.00137	CcSEcCtD
Lorazepam—Hypertension—Docetaxel—pancreatic cancer	0.00117	0.00136	CcSEcCtD
Lorazepam—Drowsiness—Epirubicin—pancreatic cancer	0.00117	0.00136	CcSEcCtD
Lorazepam—Nausea—Sunitinib—pancreatic cancer	0.00115	0.00135	CcSEcCtD
Lorazepam—Pancytopenia—Doxorubicin—pancreatic cancer	0.00115	0.00134	CcSEcCtD
Lorazepam—Asthenia—Irinotecan—pancreatic cancer	0.00115	0.00134	CcSEcCtD
Lorazepam—Jaundice—Epirubicin—pancreatic cancer	0.00114	0.00133	CcSEcCtD
Lorazepam—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00113	0.00132	CcSEcCtD
Lorazepam—Dry mouth—Docetaxel—pancreatic cancer	0.00113	0.00132	CcSEcCtD
Lorazepam—Asthenia—Gemcitabine—pancreatic cancer	0.00112	0.0013	CcSEcCtD
Lorazepam—Confusional state—Docetaxel—pancreatic cancer	0.00111	0.0013	CcSEcCtD
Lorazepam—Infection—Docetaxel—pancreatic cancer	0.0011	0.00128	CcSEcCtD
Lorazepam—Agranulocytosis—Epirubicin—pancreatic cancer	0.00109	0.00127	CcSEcCtD
Lorazepam—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00108	0.00126	CcSEcCtD
Lorazepam—Drowsiness—Doxorubicin—pancreatic cancer	0.00108	0.00126	CcSEcCtD
Lorazepam—Tachycardia—Docetaxel—pancreatic cancer	0.00108	0.00126	CcSEcCtD
Lorazepam—Bradycardia—Epirubicin—pancreatic cancer	0.00107	0.00125	CcSEcCtD
Lorazepam—Dizziness—Irinotecan—pancreatic cancer	0.00106	0.00123	CcSEcCtD
Lorazepam—Jaundice—Doxorubicin—pancreatic cancer	0.00105	0.00123	CcSEcCtD
Lorazepam—Hypotension—Docetaxel—pancreatic cancer	0.00103	0.0012	CcSEcCtD
Lorazepam—Vomiting—Irinotecan—pancreatic cancer	0.00101	0.00119	CcSEcCtD
Lorazepam—Dizziness—Fluorouracil—pancreatic cancer	0.00101	0.00118	CcSEcCtD
Lorazepam—Visual impairment—Epirubicin—pancreatic cancer	0.00101	0.00118	CcSEcCtD
Lorazepam—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00101	0.00118	CcSEcCtD
Lorazepam—Rash—Irinotecan—pancreatic cancer	0.00101	0.00118	CcSEcCtD
Lorazepam—Dermatitis—Irinotecan—pancreatic cancer	0.00101	0.00118	CcSEcCtD
Lorazepam—Headache—Irinotecan—pancreatic cancer	0.001	0.00117	CcSEcCtD
Lorazepam—Vomiting—Gemcitabine—pancreatic cancer	0.000989	0.00116	CcSEcCtD
Lorazepam—Bradycardia—Doxorubicin—pancreatic cancer	0.000987	0.00115	CcSEcCtD
Lorazepam—Somnolence—Docetaxel—pancreatic cancer	0.000981	0.00115	CcSEcCtD
Lorazepam—Rash—Gemcitabine—pancreatic cancer	0.00098	0.00115	CcSEcCtD
Lorazepam—Dermatitis—Gemcitabine—pancreatic cancer	0.00098	0.00114	CcSEcCtD
Lorazepam—Headache—Gemcitabine—pancreatic cancer	0.000974	0.00114	CcSEcCtD
Lorazepam—Vomiting—Fluorouracil—pancreatic cancer	0.000972	0.00114	CcSEcCtD
Lorazepam—Rash—Fluorouracil—pancreatic cancer	0.000964	0.00113	CcSEcCtD
Lorazepam—Dermatitis—Fluorouracil—pancreatic cancer	0.000963	0.00113	CcSEcCtD
Lorazepam—Headache—Fluorouracil—pancreatic cancer	0.000958	0.00112	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000953	0.00111	CcSEcCtD
Lorazepam—Fatigue—Docetaxel—pancreatic cancer	0.000951	0.00111	CcSEcCtD
Lorazepam—Nausea—Irinotecan—pancreatic cancer	0.000948	0.00111	CcSEcCtD
Lorazepam—Pain—Docetaxel—pancreatic cancer	0.000944	0.0011	CcSEcCtD
Lorazepam—Constipation—Docetaxel—pancreatic cancer	0.000944	0.0011	CcSEcCtD
Lorazepam—Chills—Epirubicin—pancreatic cancer	0.00094	0.0011	CcSEcCtD
Lorazepam—Arrhythmia—Epirubicin—pancreatic cancer	0.000936	0.00109	CcSEcCtD
Lorazepam—Visual impairment—Doxorubicin—pancreatic cancer	0.000934	0.00109	CcSEcCtD
Lorazepam—Alopecia—Epirubicin—pancreatic cancer	0.000926	0.00108	CcSEcCtD
Lorazepam—Nausea—Gemcitabine—pancreatic cancer	0.000924	0.00108	CcSEcCtD
Lorazepam—Erythema—Epirubicin—pancreatic cancer	0.000912	0.00107	CcSEcCtD
Lorazepam—Feeling abnormal—Docetaxel—pancreatic cancer	0.000909	0.00106	CcSEcCtD
Lorazepam—Nausea—Fluorouracil—pancreatic cancer	0.000908	0.00106	CcSEcCtD
Lorazepam—Tension—Epirubicin—pancreatic cancer	0.000895	0.00105	CcSEcCtD
Lorazepam—Nervousness—Epirubicin—pancreatic cancer	0.000886	0.00104	CcSEcCtD
Lorazepam—Chills—Doxorubicin—pancreatic cancer	0.00087	0.00102	CcSEcCtD
Lorazepam—Arrhythmia—Doxorubicin—pancreatic cancer	0.000866	0.00101	CcSEcCtD
Lorazepam—Vision blurred—Epirubicin—pancreatic cancer	0.00086	0.001	CcSEcCtD
Lorazepam—Alopecia—Doxorubicin—pancreatic cancer	0.000857	0.001	CcSEcCtD
Lorazepam—Erythema—Doxorubicin—pancreatic cancer	0.000844	0.000986	CcSEcCtD
Lorazepam—Agitation—Epirubicin—pancreatic cancer	0.000838	0.000979	CcSEcCtD
Lorazepam—Tension—Doxorubicin—pancreatic cancer	0.000828	0.000968	CcSEcCtD
Lorazepam—Nervousness—Doxorubicin—pancreatic cancer	0.00082	0.000958	CcSEcCtD
Lorazepam—Vertigo—Epirubicin—pancreatic cancer	0.000819	0.000958	CcSEcCtD
Lorazepam—Hypersensitivity—Docetaxel—pancreatic cancer	0.000813	0.00095	CcSEcCtD
Lorazepam—Vision blurred—Doxorubicin—pancreatic cancer	0.000795	0.000929	CcSEcCtD
Lorazepam—Asthenia—Docetaxel—pancreatic cancer	0.000792	0.000925	CcSEcCtD
Lorazepam—Convulsion—Epirubicin—pancreatic cancer	0.00079	0.000923	CcSEcCtD
Lorazepam—Hypertension—Epirubicin—pancreatic cancer	0.000787	0.00092	CcSEcCtD
Lorazepam—Agitation—Doxorubicin—pancreatic cancer	0.000775	0.000906	CcSEcCtD
Lorazepam—Dry mouth—Epirubicin—pancreatic cancer	0.000759	0.000887	CcSEcCtD
Lorazepam—Vertigo—Doxorubicin—pancreatic cancer	0.000758	0.000886	CcSEcCtD
Lorazepam—Confusional state—Epirubicin—pancreatic cancer	0.000751	0.000877	CcSEcCtD
Lorazepam—Infection—Epirubicin—pancreatic cancer	0.000739	0.000864	CcSEcCtD
Lorazepam—Convulsion—Doxorubicin—pancreatic cancer	0.000731	0.000854	CcSEcCtD
Lorazepam—Dizziness—Docetaxel—pancreatic cancer	0.00073	0.000853	CcSEcCtD
Lorazepam—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000729	0.000852	CcSEcCtD
Lorazepam—Hypertension—Doxorubicin—pancreatic cancer	0.000729	0.000851	CcSEcCtD
Lorazepam—Tachycardia—Epirubicin—pancreatic cancer	0.000726	0.000849	CcSEcCtD
Lorazepam—Dry mouth—Doxorubicin—pancreatic cancer	0.000703	0.000821	CcSEcCtD
Lorazepam—Vomiting—Docetaxel—pancreatic cancer	0.000702	0.00082	CcSEcCtD
Lorazepam—Rash—Docetaxel—pancreatic cancer	0.000696	0.000813	CcSEcCtD
Lorazepam—Hypotension—Epirubicin—pancreatic cancer	0.000696	0.000813	CcSEcCtD
Lorazepam—Dermatitis—Docetaxel—pancreatic cancer	0.000695	0.000812	CcSEcCtD
Lorazepam—Confusional state—Doxorubicin—pancreatic cancer	0.000694	0.000811	CcSEcCtD
Lorazepam—Headache—Docetaxel—pancreatic cancer	0.000691	0.000808	CcSEcCtD
Lorazepam—Infection—Doxorubicin—pancreatic cancer	0.000684	0.0008	CcSEcCtD
Lorazepam—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000674	0.000788	CcSEcCtD
Lorazepam—Tachycardia—Doxorubicin—pancreatic cancer	0.000672	0.000785	CcSEcCtD
Lorazepam—Somnolence—Epirubicin—pancreatic cancer	0.000662	0.000773	CcSEcCtD
Lorazepam—Nausea—Docetaxel—pancreatic cancer	0.000655	0.000766	CcSEcCtD
Lorazepam—Hypotension—Doxorubicin—pancreatic cancer	0.000644	0.000752	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000643	0.000751	CcSEcCtD
Lorazepam—Fatigue—Epirubicin—pancreatic cancer	0.000642	0.00075	CcSEcCtD
Lorazepam—Pain—Epirubicin—pancreatic cancer	0.000637	0.000744	CcSEcCtD
Lorazepam—Constipation—Epirubicin—pancreatic cancer	0.000637	0.000744	CcSEcCtD
Lorazepam—Feeling abnormal—Epirubicin—pancreatic cancer	0.000613	0.000717	CcSEcCtD
Lorazepam—Somnolence—Doxorubicin—pancreatic cancer	0.000612	0.000715	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000595	0.000695	CcSEcCtD
Lorazepam—Fatigue—Doxorubicin—pancreatic cancer	0.000594	0.000694	CcSEcCtD
Lorazepam—Pain—Doxorubicin—pancreatic cancer	0.000589	0.000688	CcSEcCtD
Lorazepam—Constipation—Doxorubicin—pancreatic cancer	0.000589	0.000688	CcSEcCtD
Lorazepam—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000568	0.000663	CcSEcCtD
Lorazepam—Hypersensitivity—Epirubicin—pancreatic cancer	0.000548	0.000641	CcSEcCtD
Lorazepam—Asthenia—Epirubicin—pancreatic cancer	0.000534	0.000624	CcSEcCtD
Lorazepam—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000507	0.000593	CcSEcCtD
Lorazepam—Asthenia—Doxorubicin—pancreatic cancer	0.000494	0.000577	CcSEcCtD
Lorazepam—Dizziness—Epirubicin—pancreatic cancer	0.000492	0.000575	CcSEcCtD
Lorazepam—Vomiting—Epirubicin—pancreatic cancer	0.000473	0.000553	CcSEcCtD
Lorazepam—Rash—Epirubicin—pancreatic cancer	0.000469	0.000548	CcSEcCtD
Lorazepam—Dermatitis—Epirubicin—pancreatic cancer	0.000469	0.000548	CcSEcCtD
Lorazepam—Headache—Epirubicin—pancreatic cancer	0.000466	0.000545	CcSEcCtD
Lorazepam—Dizziness—Doxorubicin—pancreatic cancer	0.000455	0.000532	CcSEcCtD
Lorazepam—Nausea—Epirubicin—pancreatic cancer	0.000442	0.000517	CcSEcCtD
Lorazepam—Vomiting—Doxorubicin—pancreatic cancer	0.000438	0.000512	CcSEcCtD
Lorazepam—Rash—Doxorubicin—pancreatic cancer	0.000434	0.000507	CcSEcCtD
Lorazepam—Dermatitis—Doxorubicin—pancreatic cancer	0.000434	0.000507	CcSEcCtD
Lorazepam—Headache—Doxorubicin—pancreatic cancer	0.000431	0.000504	CcSEcCtD
Lorazepam—Nausea—Doxorubicin—pancreatic cancer	0.000409	0.000478	CcSEcCtD
